Back to Results
First PageMeta Content
Comprehensive Drug Abuse Prevention and Control Act / Controlled Substances Act / New Drug Application / Substance abuse / Food and Drug Administration / Drug Enforcement Administration / National Institute on Drug Abuse / Convention on Psychotropic Substances / Removal of cannabis from Schedule I of the Controlled Substances Act / Government / Research / Pharmaceutical sciences


Microsoft Word - 5265dft.doc
Add to Reading List

Open Document

File Size: 274,85 KB

Share Result on Facebook

City

Rockville / /

Country

United States / /

Facility

New Hampshire Avenue Bldg. / /

/

IndustryTerm

pharmacological site / drug product / proposed drug product / mechanical devices / physical and chemical properties / transdermal systems / neurotransmitter systems / active pharmaceutical ingredient / marketed drug product / manufacturing / chemical structure / drug products / affinity site / /

MedicalCondition

hallucinations / disorder / chronic / neurobiological disorder / /

MedicalTreatment

dialysis / /

Organization

U.S. Department of Health and Human Services / Food and Drug Administration Center for Drug Evaluation and Research / Food and Drug Administration / National Institute on Drug Abuse / American Academy of Pain Medicine / U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research / American Society of Addiction Medicine / Division of Dockets Management / American Pain Society / office of Communications Division / Drug Enforcement Administration / Drug Information Center for Drug Evaluation / /

Person

Corinne Moody / /

/

Position

researcher / Secretary / Director / Assistant Secretary / Chief Counsel / Commissioner / /

ProvinceOrState

Maryland / /

Technology

tomography / Pharmacokinetics / Pharmacodynamics / drug development / dialysis / /

URL

http /

SocialTag